Fund Holdings — FCPM III SERVICES B.V.

Total Portfolio Value:
$1.06B
Total Bought:
$591.88M
Total Sold:
$46.82M
Net Transaction:
+$545.06M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Braveheart Bio Inc021,826,024+21,826,024$0$440.89M41.57%+$440.89M
Newamsterdam Pharma Company
ORDINARY SHARES
8,490,3538,490,3530$287.74M$206.49M19.47%-$81.25M
Korsana Biosciences Inc02,192,155+2,192,155$0$70.15M6.61%+$70.15M
Vor Biopharma Inc.(VOR)4,117,3543,405,279-712,075$75.80M$64.97M6.13%-$10.83M
Dyne Therapeutics, Inc.(DYN)3,848,2563,586,796-261,460$85.47M$57.78M5.45%-$27.69M
Damora Therapeutics, Inc.(DMRA)2,441,0002,441,0000$63.49M$51.94M4.90%-$11.55M
Maplight Therapeutics Inc3,226,4004,428,328+1,201,928$115.63M$45.12M4.25%-$70.51M
Aura Biosciences Inc4,053,7755,248,841+1,195,066$28.78M$32.96M3.11%+$4.18M
Crescent Biopharma Inc.1,677,8522,022,679+344,827$30.20M$29.51M2.78%-$690.4K
Replimune Group, Inc.(REPL)2,808,3681,720,500-1,087,868$31.09M$22.78M2.15%-$8.31M
Engene Holdings Inc
COM
9,632,5619,632,5610$16.66M$19.27M1.82%+$2.60M
Bicycle Therapeutics PlcADS3,468,4303,468,4300$14.71M$12.76M1.20%-$1.94M
Tarsus Pharmaceuticals, Inc.(TARS)064,087+64,087$0$5.04M0.47%+$5.04M
Engene Holdings IncW EXP 10 31 2028
*W EXP 10/31/202
2,878,1482,878,1480$834.4K$575.6K0.05%-$258.7K
Lisata Therapeutics Inc0297,478+297,478$0$428.4K0.04%+$428.4K
Page 1 of 1
FCPM III SERVICES B.V. — 13F Holdings — Q3 2026 | TickerTrail